Sickle Cell Disease
Drepanocytosis / Hemoglobin S (HbS) Hemoglobinopathy

Comprehensive Medical Definition
Sickle Cell Disease (SCD) is an inherited red blood cell disorder caused by a single point mutation in the beta-globin gene on chromosome 11. Under deoxygenated conditions, abnormal hemoglobin molecules (HbS) polymerize into long, stiff rods within red cells, stretching them into rigid, crescent-like 'sickles.' Unlike normal flexible erythrocytes that glide effortlessly through capillaries, sickle cells become sticky and fragile, clogging microvascular blood vessels, impeding oxygen delivery, and prematurely breaking down within 10 to 20 days.
Clinical Presentation & Primary Symptoms
Treatment Protocols & Clinical Management
- Daily disease-modifying Hydroxyurea therapy to boost protective Fetal Hemoglobin (HbF)
- Daily prophylactic folic acid supplementation
- Pneumococcal and meningococcal immunizations plus prophylactic penicillin
- Rapid intravenous hydration and protocol-driven analgesia during vaso-occlusive crises
- Safe, leukodepleted blood transfusions for acute chest syndrome or stroke risk
- Curative Allogeneic Bone Marrow / Stem Cell Transplantation for eligible candidates
Potential Complications Requiring Vigilance
Gold Standard Screening
Automated High-Performance Liquid Chromatography (HPLC) & Confirmatory Genetic Testing
Government Welfare Entitlement
Classified as a benchmark disability under the Rights of Persons with Disabilities (RPwD) Act, 2016. Entitled to official Government UDID Cards, medical travel concessions, and educational scholarships.
Read About Our UDID Card MilestonePremarital Carrier Screening
Universal premarital carrier screening with HPLC testing prevents carrier-to-carrier marriages, safeguarding future generations against inheriting clinical sickle cell disease.
